menopause. Menopausal and female climacteric states
Conditions
Interventions
Intervention 1: Intervention group:omega3 1 tablet 1000 mg daily, group folic acid 1 tablet 1 mg daily?omega3 is made zahravi , folic acid made Shahid Beheshti University of Medical Science in the Sc
Placebo
Intervention group:omega3 1 tablet 1000 mg daily, group folic acid 1 tablet 1 mg daily?omega3 is made zahravi , folic acid made Shahid Beheshti University of Medical Science in the School of Pharmacy
Control group: placebo 1 tablet daily for 3 months , made School of Pharmacy Shahid, Beheshti University of Medical Sciences
Sponsors
Vice chancellor for research, Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : Iranian, age 45-60 years, menopause is the normal type have,reporting at least two times hot flashes per day , with literacy being studied components or a family member, body mass index 20 to 30, non receiving hormone therapy , anti-depressants or tranquilizers, supplements and herbal medicines, no known underlying disease (hypertension, diabetes, epilepsy, etc.), the lack of experience of such as relatives died in the last 6 months of stress, separation of spouses and absence of estrogen-dependent cancer, non consumption of more than 2 servings of fish per weeks, insensitivity to fish or fish oil, seafood, avoiding the use of any drugs to improve the symptoms of hot flashes, at least one year and a maximum of three years have menstruation, exercise not more than 2 times a week for 20-30Dqyqh,Exclusion criteria: the other drug use during the study, in case of complications or allergic drugs (omega-3 or folic acid), identifying any physical or mental illness during the study, lack of proper use of drugs or placebo over three days
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The severity of hot flashes. Timepoint: Before the intervention, one month and two months and three months after intervention. Method of measurement: Daily hot flash diary form. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of hot flashes. Timepoint: Before the intervention, one month and two months and three months after intervention. Method of measurement: Daily hot flash diary form.;Frequency hot flashes. Timepoint: Before the intervention, one month and two months and three months after intervention. Method of measurement: Daily hot flash diary form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactmasoumeh chamani
Iran University of Medical Sciences, School of Nursing and Midwifery
Outcome results
None listed